Cuadra, Emie Flor T.
HRN: 12-05-55 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/28/2023
CEFUROXIME 1.5GM (VIAL)
02/28/2023
03/01/2023
IVT
1.5g
Q8 X 3 Doses
UTI; Pus Cells: 15-20; Bacteria: Moderate
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes